SARS-CoV-2 Antinucleocapsid Antibody Response of mRNA and Inactivated Virus Vaccines Compared to Unvaccinated Individuals.

Qaqish, Arwa; Abbas, Manal Mohammad; Al-Tamimi, Mohammad; Abbas, Manal Ahmad; Al-Omari, Mariam; Alqassieh, Rami

Qaqish, Arwa; Abbas, Manal Mohammad; Al-Tamimi, Mohammad; Abbas, Manal Ahmad; Al-Omari, Mariam; Alqassieh, Rami.

Afiliação

Qaqish A; Department of Biology and Biotechnology, The Hashemite University, Zarqa 13133, Jordan.
Abbas MM; Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman 19328, Jordan.
Al-Tamimi M; Pharmacological and Diagnostic Research Lab, Al-Ahliyya Amman University, Amman 19328, Jordan.
Abbas MA; Department of Basic Medical Sciences, Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan.
Al-Omari M; Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al-Ahliyya Amman University, Amman 19328, Jordan.
Alqassieh R; Pharmacological and Diagnostic Research Lab, Al-Ahliyya Amman University, Amman 19328, Jordan.

Vaccines (Basel) ; 10(5)2022 Apr 20.

Article em En | MEDLINE | ID: mdl-35632399

Palavras-chave

COVID-19; IgG; IgM; Pfizer; SARS-CoV-2; Sinopharm; anti-N; anti-S

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Vaccines (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Jordânia